Phase
Condition
Geographic Atrophy
Macular Degeneration
Treatment
SKG0106
Clinical Study ID
Ages > 50 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Subjects who only meet all of the following criteria are eligible for this study:
- nAMD subjects who have been enrolled in the SKG0106-related study and received SKG0106injection;
- Subjects who voluntarily sign an informed consent form (ICF) and comply with theprotocol to complete the study
Exclusion
Exclusion Criteria:
- Subjects who are judged by the investigator unsuitable for this study
Study Design
Connect with a study center
The Second Hospital Of Anhui Medical University
Hefei, Anhui
ChinaSite Not Available
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang
ChinaSite Not Available
Eye Hospital, WMU (Zhejiang Eye Hospital)
Wenzhou, Zhejiang
ChinaSite Not Available
Beijing Hospital
Beijing,
ChinaSite Not Available
Peking Union Medical College Hospital
Beijing,
ChinaActive - Recruiting
EYE & ENT Hospital of Fudan University
Shanghai,
ChinaActive - Recruiting
Xinhua Hospital Affiliated To Shanghai Jiao Tong University School Of Medicine
Shanghai,
ChinaSite Not Available
Ophthalmic Consultants of Boston
Boston, Massachusetts 02114
United StatesSite Not Available
Retina Consultants of Texas
Katy, Texas 77494
United StatesSite Not Available
Wagner Macula & Retina Center
Norfolk, Virginia 23502
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.